Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two randomized crossover non-inferiority studies

NASAL GLUCAGON DELIVERY IS MORE SUCCESSFUL THAN INJECTABLE DELIVERY: A SIMULATED SEVERE HYPOGLYCEMIA RESCUE

(2020) Julie A. Settles et al.   Endocrine Practice

6. Glycemic Targets: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation

(2019) Virginia Valentine et al.   Diabetes Technology & Therapeutics

Human factors studies of a prefilled syringe with stable liquid glucagon in a simulated severe hypoglycemia rescue situation

(2019) Brett Newswanger et al.   Expert Opinion on Drug Delivery

Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes

(2017) Morey W Haymond et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

(2016) Jennifer L. Sherr et al.   DIABETES CARE

Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study

(2016) Morey W. Haymond et al.   DIABETES CARE

GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN

(2016) Beth D. Mitchell et al.   Endocrine Practice

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

(2015) Michael R. Rickels et al.   DIABETES CARE

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach

(2011) Kedia   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy